Ambee Pharmaceuticals Ltd. reported earnings results for the third quarter and nine months ended March 2018. For the quarter, EPS was BDT 0.95 against BDT 0.92 a year ago. For the nine months, EPS was BDT 2.52 against BDT 2.32 a year ago. NOCFPS was BDT 3.51 against BDT 8.33 a year ago. NAV per share was BDT 24.76 as on March 31, 2018.